Cargando…
Pioglitazone protects blood vessels through inhibition of the apelin signaling pathway by promoting KLF4 expression in rat models of T2DM
Apelin, identified as the endogenous ligand of APJ, exerts various cardiovascular effects. However, the molecular mechanism underlying the regulation of apelin expression in vascular cells is poorly described. Pioglitazone (PIO) and Krüppel-like factor 4 (KLF4) exhibit specific biological functions...
Autores principales: | Wang, Ying, Zhang, Ruonan, Shen, Hailin, Kong, Jing, Lv, Xinrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928522/ https://www.ncbi.nlm.nih.gov/pubmed/31829402 http://dx.doi.org/10.1042/BSR20190317 |
Ejemplares similares
-
Mechanism of KLF4 Protection against Acute Liver Injury via Inhibition of Apelin Signaling
por: Ji, Weitao, et al.
Publicado: (2019) -
Apelin-13 alleviated cardiac fibrosis via inhibiting the PI3K/Akt pathway to attenuate oxidative stress in rats with myocardial infarction-induced heart failure
por: Zhong, Shan, et al.
Publicado: (2020) -
ALK5 deficiency inhibits macrophage inflammation and lipid loading by targeting KLF4
por: Li, Wenyan, et al.
Publicado: (2020) -
Dexamethasone prophylaxis protects from acute high-altitude illness by modifying the peripheral blood mononuclear cell inflammatory transcriptome
por: Kumar, Rahul, et al.
Publicado: (2023) -
Colchicine protects against the development of experimental abdominal aortic aneurysm
por: Zhao, Yi, et al.
Publicado: (2023)